Literature DB >> 30312975

Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention.

Sabato Sorrentino1,2, Usman Baber1, Bimmer E Claessen1, Anton Camaj1, Birgit Vogel1, Samantha Sartori1, Paul Guedeney1, Jaya Chandrasekhar1, Serdar Farhan1, Nitin Barman1, Joseph Sweeny1, Gennaro Giustino1, George Dangas1, Annapoorna Kini1, Samin Sharma1, Roxana Mehran1.   

Abstract

BACKGROUND: Although several variables have been identified as bleeding determinants (BDs), their occurrence and predictive value in patients undergoing percutaneous coronary intervention (PCI) in the real world remain unclear. We aimed to characterize the rate of BDs in patients undergoing PCI with stent implantation in a large volume tertiary centre.
METHODS: We included patients undergoing coronary stenting at our institution from January 2012 to December 2016, and defined post-discharge bleeding (PDB) as bleeding requiring hospitalization or transfusion. Several BDs, identified by the PARIS bleeding and PRECISE-DAPT scores and inclusion criteria of the LEADERS FREE trial, were analysed.
RESULTS: In a population of 10,406 subjects who underwent PCI, 2,938 patients (28.2%) had 1, 2,367 (22.8%) had 2 and 2,913 (28.0%) had ≥3 pre-specified BD. Compared with patients without PDB, subjects who experienced PDB were older (70.43 ± 11.94 vs. 65.90 ± 11.54 years, p < 0.0001) with a higher prevalence of common cardiovascular risk factors. One-year PDB occurred in 177 patients (2.4%), and consistently increased according to the number of BDs involved (1.12, 2.11 and 4.35%, respectively; p < 0.0001). Analogously, 1-year rates of post-discharge myocardial infarction or stent thrombosis increased according to the number of BDs (2.44, 3.38 and 4.87%, respectively; p < 0.0001). Only 7 BDs remained independently associated with PDB at 1 year, with anaemia, oral anticoagulant at discharge and malignancy representing the strongest predictors of such risk.
CONCLUSION: Many risk factors predispose to PDB; they were often clustered together and conferred additive PDB risk at 1-year of follow-up. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30312975     DOI: 10.1055/s-0038-1673687

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Sabato Sorrentino; Phong Nguyen; Nadia Salerno; Alberto Polimeni; Jolanda Sabatino; Angela Makris; Annemarie Hennessy; Gennaro Giustino; Carmen Spaccarotella; Annalisa Mongiardo; Salvatore De Rosa; Craig Juergens; Ciro Indolfi
Journal:  J Clin Med       Date:  2020-03-03       Impact factor: 4.241

2.  Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients: A real world retrospective study.

Authors:  Yue-Cheng Hu; Wei-Jie Yao; Dong-Xia Jin; Jing-Xia Zhang; Le Wang; Rui Zhang; Jing-Han Xu; Hong-Liang Cong
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

3.  Efficacy and safety of bivalirudin vs heparin in patients with coronary heart disease undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.

Authors:  Xiao-Qiang Liu; Xian-Du Luo; Yan-Qing Wu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

4.  1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry.

Authors:  Jaya Chandrasekhar; Usman Baber; Samantha Sartori; Melissa B Aquino; Petr Hájek; Borislav Atzev; Martin Hudec; Tiong Kiam Ong; Martin Mates; Borislav Borisov; Hazem M Warda; Peter den Heijer; Jaroslaw Wojcik; Andres Iniguez; Zdeněk Coufal; Ahmed Khashaba; Muhammad Munawar; Robert T Gerber; Bryan P Yan; Paula Tejedor; Petr Kala; Houng Bang Liew; Michael Lee; Deborah N Kalkman; George D Dangas; Robbert J de Winter; Antonio Colombo; Roxana Mehran
Journal:  Int J Cardiol Heart Vasc       Date:  2020-09-06

5.  Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies.

Authors:  Rishi Chandiramani; Davide Cao; Bimmer E Claessen; Sabato Sorrentino; Paul Guedeney; Moritz Blum; Ridhima Goel; Anastasios Roumeliotis; Mitchell Krucoff; Ken Kozuma; Junbo Ge; Ashok Seth; Raj Makkar; Sripal Bangalore; Deepak L Bhatt; Dominick J Angiolillo; Karine Ruster; Jin Wang; Shigeru Saito; Franz-Josef Neumann; James Hermiller; Marco Valgimigli; Roxana Mehran
Journal:  J Am Heart Assoc       Date:  2020-03-30       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.